Literature DB >> 8369910

Infrainguinal vein graft stenosis.

K Varty1, K E Allen, P R Bell, N J London.   

Abstract

Although knowledge of the biological processes involved in the development of intimal hyperplasia has increased markedly in recent years, the precise aetiology of infrainguinal vein graft stenosis remains undetermined. Current therapy is therefore directed at treatment of the established lesion rather than its prevention. There seems little doubt, however, that recent advances in understanding of the vascular biology of normal and pathological saphenous vein will eventually lead to specific targeted therapy that will allow the prevention of vein graft stenosis.

Entities:  

Mesh:

Year:  1993        PMID: 8369910     DOI: 10.1002/bjs.1800800706

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes.

Authors:  J Bloor; N Shukla; F C T Smith; G D Angelini; J Y Jeremy
Journal:  Diabetologia       Date:  2010-02-25       Impact factor: 10.122

Review 2.  Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology.

Authors:  Y G Wilson
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

3.  Neointima development in externally stented saphenous vein grafts.

Authors:  Przemysław Węglarz; Michał Krejca; Maria Trusz-Gluza; Krystyna Bochenek; Ewa Konarska-Kuszewska; Krzysztof Szydło; Piotr Kuszewski; Christopher L Jackson; Gianni D Angelini; Grzegorz Bajor
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.